Dieter Hoelzer, MD, PhD, is currently a Hematologist/Oncologist and Professor of Internal Medicine at the University of Frankfurt, Frankfurt, Germany. He also founded the ONKOLOGIKUM Frankfurt am Museumsufer, Frankfurt, Germany, where he is Director.
Prof. Hoelzer was one of the five founding members and President of the European Hematology Association (EHA). He is also the former Vice President of the European Society for Clinical Investigation, President of the South-German Hemoblastis Group, and Vice President of the European School of Hematology.
Prof. Hoelzer is the recipient of many awards such as the Johann-Georg- Zimmermann-Price, the San Salvatore Award, and the European Leukemia Network Merit Award and is an honorary member of the Hematological Societies of Austria, Hungary, and Germany.
Speaking on acute leukemia therapeutics
Prof. Hoelzer’s main research interest lies in the development of novel therapeutic strategies for the treatment of acute leukemias. Prof. Hoelzer is Principal Investigator of numerous Phase IV trials investigating the treatment of newly diagnosed acute lymphoblastic leukemia in adults and in elderly patients (NCT00198978; NCT00198991; NCT00199056).